ro 22-1319 has been researched along with perphenazine in 1 studies
| Studies (ro 22-1319) | Trials (ro 22-1319) | Recent Studies (post-2010) (ro 22-1319) | Studies (perphenazine) | Trials (perphenazine) | Recent Studies (post-2010) (perphenazine) |
|---|---|---|---|---|---|
| 23 | 3 | 0 | 1,666 | 243 | 128 |
| Protein | Taxonomy | ro 22-1319 (IC50) | perphenazine (IC50) |
|---|---|---|---|
| ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | 14.79 | |
| Aldehyde oxidase 1 | Mus musculus (house mouse) | 6.1 | |
| Retinal dehydrogenase 1 | Homo sapiens (human) | 0.5242 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 4.216 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0003 | |
| Pleiotropic ABC efflux transporter of multiple drugs | Saccharomyces cerevisiae S288C | 1.4 | |
| Aldehyde oxidase | Homo sapiens (human) | 0.033 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 4.216 | |
| Aldehyde oxidase 1 | Macaca fascicularis (crab-eating macaque) | 3.6 | |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | 4.216 | |
| Aldehyde oxidase 1 | Rattus norvegicus (Norway rat) | 0.74 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakigi, T; Kaneda, H; Shintani, T; Tanimoto, K; Terada, T | 1 |
1 other study(ies) available for ro 22-1319 and perphenazine
| Article | Year |
|---|---|
Comparison of prolactin responses to D-1 and D-2 antagonists in rats: Ro 22-1319 is a potent D-2 antagonist.
Topics: Animals; Antipsychotic Agents; Benzazepines; Domperidone; Fluphenazine; Haloperidol; Isoquinolines; Male; Perphenazine; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1989 |